CMS’ BALANCE Model Aims To Resolve Medicare Coverage Of Weight-Loss Drugs

CMS has launched the BALANCE Model, a five-year test to lower costs & expand Medicare access to GLP-1 weight-loss drugs while ...
Forbes

Adoption Of Model-Informed Drug Development Can Improve Pharma ROI

Inflation and the Covid-19 pandemic have put pharmaceutical productivity front and center in recent years. Thus, drug companies are under mounting pressure to prove that new treatments are safe and ...
The American Journal of Managed Care

Medicare $2 Drug List Model Could Have Reduced 2021 Out-of-Pocket Generic Costs

Implementing the Medicare $2 drug list model would have reduced out-of-pocket spending by 63% for Part D beneficiaries in 2021. The model caps cost-sharing at $2 for a 30-day supply of 101 generic ...
WMUR

President Trump calls new drug pricing deal 'the biggest thing ever'

President Donald Trump says it's the biggest thing to happen to drug pricing. The White House says 9 drug manufacturers have agreed to give Medicaid in all 50 states access to most favored nation ...